Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards
Abstract Myeloid-derived suppressor cells (MDSCs) have emerged as major regulators of immune responses in cancer and other pathological conditions. In recent years, ample evidence supports key contributions of MDSC to tumour progression through both immune-mediated mechanisms and those not directly...
Guardado en:
Autores principales: | Vincenzo Bronte, Sven Brandau, Shu-Hsia Chen, Mario P. Colombo, Alan B. Frey, Tim F. Greten, Susanna Mandruzzato, Peter J. Murray, Augusto Ochoa, Suzanne Ostrand-Rosenberg, Paulo C. Rodriguez, Antonio Sica, Viktor Umansky, Robert H. Vonderheide, Dmitry I. Gabrilovich |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7c32c093ca484097b5efdfd00dee7e64 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Targeting myeloid-derived suppressor cells for cancer therapy
por: Hongchao Tang, et al.
Publicado: (2021) -
Oleate but not stearate induces the regulatory phenotype of myeloid suppressor cells
por: Hao Wu, et al.
Publicado: (2017) -
Immune suppressive activity of myeloid-derived suppressor cells in cancer requires inactivation of the type I interferon pathway
por: Kevin Alicea-Torres, et al.
Publicado: (2021) -
Myeloid-derived suppressor cells and the pathogenesis of human immunodeficiency virus infection
por: Mahmoud Mohammad Yaseen, et al.
Publicado: (2021) -
Recontextualising the style of naming in nomenclature
por: Paul Rummy, et al.
Publicado: (2021)